Matt Mefford1, Monika M Safford2, Paul Muntner1, Raegan W Durant3, Todd M Brown4, Emily B Levitan5. 1. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. 2. Department of Internal Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA. 3. Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 4. Division of Cardiovascular Disease, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 5. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: elevitan@uab.edu.
Abstract
BACKGROUND: Lack of health insurance may adversely impact medication adherence and the control of cardiovascular risk factors. We examined if the association between insurance and LDL-C is due to self-reported low medication adherence. METHODS: This cross-sectional study included 8685 black and white men and women aged 45 and older who participated in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort and used statins. Medication adherence was assessed using the 4-item Morisky Medication Adherence Scale (MMAS-4). Mean differences in LDL-C between participants with and without insurance were calculated using generalized linear models before and after adjustment for MMAS-4. Subgroups stratified by age, annual household income, diabetes, and CHD were compared. Separately, individual MMAS-4 questions were examined for mediation effects. RESULTS: After multivariable adjustment but without MMAS-4, LDL-C was 2.5mg/dL (95% CI -0.6, 5.6) higher among uninsured versus insured participants. After further adjustment for MMAS-4, LDL-C was 2.6mg/dL (95% CI -0.5, 5.6) higher. Stratified analyses produced similar results. No mediating effect was observed when each MMAS-4 question was examined separately. CONCLUSION: High medication adherence does not mediate the association between having health insurance and lower LDL-C.
BACKGROUND: Lack of health insurance may adversely impact medication adherence and the control of cardiovascular risk factors. We examined if the association between insurance and LDL-C is due to self-reported low medication adherence. METHODS: This cross-sectional study included 8685 black and white men and women aged 45 and older who participated in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort and used statins. Medication adherence was assessed using the 4-item Morisky Medication Adherence Scale (MMAS-4). Mean differences in LDL-C between participants with and without insurance were calculated using generalized linear models before and after adjustment for MMAS-4. Subgroups stratified by age, annual household income, diabetes, and CHD were compared. Separately, individual MMAS-4 questions were examined for mediation effects. RESULTS: After multivariable adjustment but without MMAS-4, LDL-C was 2.5mg/dL (95% CI -0.6, 5.6) higher among uninsured versus insured participants. After further adjustment for MMAS-4, LDL-C was 2.6mg/dL (95% CI -0.5, 5.6) higher. Stratified analyses produced similar results. No mediating effect was observed when each MMAS-4 question was examined separately. CONCLUSION: High medication adherence does not mediate the association between having health insurance and lower LDL-C.
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Marie A Krousel-Wood; Paul Muntner; Tareq Islam; Donald E Morisky; Larry S Webber Journal: Med Clin North Am Date: 2009-05 Impact factor: 5.456
Authors: Emily B Levitan; Virginia J Howard; Mary Cushman; Suzanne E Judd; Stephanie E Tison; Ya Yuan; Debora Kamin Mukaz; Henry E Wang; Nathalie Pamir; Timothy B Plante; Stephen P Juraschek; Monika M Safford; Parag Goyal Journal: BMC Public Health Date: 2021-12-11 Impact factor: 3.295